PROBIOTICS FOR TREATING DIAPER DERMATITIS IN CHILDREN - A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED CLINICAL TRIAL
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Diaper Dermatitis
- Sponsor
- University Maribor
- Enrollment
- 42
- Locations
- 1
- Primary Endpoint
- Duration of diaper dermatis
- Status
- Recruiting
- Last Updated
- 5 months ago
Overview
Brief Summary
The goal of this randomized controlled clinical trial is to determine the effect of the probiotic OMNiBiOTiC® Panda in treating diaper dermatitis in children under the age of two years. The main question it aims to answer is:
Is the probiotic OMNiBiOTiC® Panda effective in reducing the duration of diaper dermatitis in children under the age of two years?
Researchers will compare the probiotic and placebo group to see if the duration of diaper dermatitis is significant among the two groups.
Participants will:
- receive 6 droplets daily of probiotic or placebo for 3 weeks and
- observe and record improvement of diaper rash symptoms each day using a diary.
Investigators
Sabina Fijan
Assoc. Prof. Dr.
University Maribor
Eligibility Criteria
Inclusion Criteria
- •presence of diaper dermatitis
- •age less than two years
Exclusion Criteria
- •previous use of probiotics
- •age more than two years
- •an acute bacterial infection
- •chronic disease
- •local use of antibiotics in the anogenital region
Outcomes
Primary Outcomes
Duration of diaper dermatis
Time Frame: 3 weeks supplementation
Comparison of the duration of diaper dermatitis in children younger than two years in both arms via daily the use of the diary.